Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages

Kaixiang Zhu1,2,3, Xuexiao Jin1, Zhexu Chi4

  • 1Institute of Immunology and Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, P. R. China.

Insights

The nucleotide-binding domain, leucine-rich-repeat containing family, pyrin domain-containing 3 (NLRP3) inflammasome priming requires Ser725 phosphorylation, directly regulated by misshapen (Msn)/NIK-related kinase 1 (MINK1). This discovery offers potential therapeutic targets for inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Signaling

Background:

  • The NLRP3 inflammasome is crucial for inflammation and inflammatory diseases.
  • NLRP3 phosphorylation regulates inflammasome activation, but the role of Ser725 remains unclear.

Purpose of the Study:

  • To investigate the importance and regulation of NLRP3 Ser725 phosphorylation.
  • To identify the kinase responsible for NLRP3 Ser725 phosphorylation and its role in inflammasome activation.

Main Methods:

  • Macrophage cell models
  • Biochemical assays to study protein interactions and phosphorylation
  • Mouse models of acute sepsis and peritonitis

Main Results:

  • NLRP3 Ser725 phosphorylation is essential for inflammasome priming in macrophages.
  • Misshapen (Msn)/NIK-related kinase 1 (MINK1) directly phosphorylates NLRP3 at Ser725.
  • MINK1 deficiency and ROS inhibition reduce NLRP3 activation and inflammatory symptoms in vivo.

Conclusions:

  • MINK1 directly regulates NLRP3 inflammasome priming via Ser725 phosphorylation.
  • MINK1 kinase activity, modulated by ROS, is critical for NLRP3 inflammasome activation.
  • Targeting MINK1 offers a potential therapeutic strategy for NLRP3-mediated inflammatory diseases.